30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Schobel Alexander Mark

Insider profile

Performance

Overall performance
2.2

Performance over holding periods
2.2
30 days 90 days 120 days
Average return -21% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Schobel Alexander Mark's trades of Aquestive Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-03-19 2024-03-15 PlS Planned sale
16,455 -40.9%
362.80
US$4,172,492
16,455 -40.9% 362.80 US$4,172,492
2024-03-15 2024-03-15 PrS Proposed sale
89,842
359.60
US$4,998,558
89,842 359.60 US$4,998,558
2024-03-12 2024-03-08 PlS Planned sale
9,350 +8.9%
87.76
US$4,188,645
9,350 +8.9% 87.76 US$4,188,645
2024-03-08 2024-03-08 PrS Proposed sale
25,000
5.60
US$140,000
25,000 5.60 US$140,000
2022-06-10 2022-06-08 B Purchase
45,871 +5.5%
0.96
US$44,036
45,871 +5.5% 0.96 US$44,036
2021-02-10 2021-02-10 PlS Planned sale
23,460 -2.7%
6.75
US$158,355
23,460 -2.7% 6.75 US$158,355
2021-02-10 2021-02-09 PlS Planned sale
11,540 -1.3%
6.75
US$77,895
11,540 -1.3% 6.75 US$77,895
2021-02-09 2021-02-08 PlS Planned sale
40,792 -4.5%
6.50
US$265,148
40,792 -4.5% 6.50 US$265,148
2020-05-11 2020-05-08 PlS Planned sale
40,000 -4.2%
5.00
US$200,000
40,000 -4.2% 5.00 US$200,000
2020-05-01 2020-04-29 PlS Planned sale
40,000 -3.8%
4.50
US$180,000
40,000 -3.8% 4.50 US$180,000
2020-05-04 2020-04-27 PlS Planned sale
40,000 -4.1%
4.00
US$160,000
40,000 -4.1% 4.00 US$160,000
2020-05-04 2020-04-14 PlS Planned sale
40,000 -3.9%
3.70
US$148,000
40,000 -3.9% 3.70 US$148,000